Tuesday, June 30, 2020
Gilead Sciences is charging American patients with private insurance more than $3,000 for its COVID-19 treatment. ICU beds in COVID hot spots across the South and West are filling up and demand for COVID tests is quickly outpacing supply.
The Gist Healthcare Podcast · Gist Healthcare Daily
June 30, 20206m 5s
Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Gilead Sciences is charging American patients with private insurance more than $3,000 for its COVID-19 treatment. ICU beds in COVID hot spots across the South and West are filling up and demand for COVID tests is quickly outpacing supply.
Hosted on Acast. See acast.com/privacy for more information.